Assessment of Clinically Relevant Drug Interactions by Online Programs in Renal Transplant Recipients

Creative Commons License

Tecen-Yucel K., Bayraktar-Ekincioglu A., YILDIRIM T., YILMAZ Ş. R., Demirkan K., ERDEM Y.

JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, vol.26, no.10, pp.1291-1296, 2020 (SCI-Expanded) identifier identifier identifier


BACKGROUND: Potential drug-drug interactions (pDDIs) with immunosuppressive drugs are frequently observed in renal transplant recipients. Drug interaction programs are acknowledged as a fundamental tool to alert physicians to pDDIs, but there is a high concern about variation among different programs in terms of quality and reliability of information.